{"entity":{"type":"insider","cik":"0001543779","url":"/insider/0001543779","json_url":"/insider/0001543779.json","name":"Knell Michael Gunnar","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":20,"n_filings":10,"first":"2020-08-10","last":"2026-08-10","span_basis":"filed_date"},"name_variants":[{"name":"Knell Michael Gunnar","source":"filing","n_filings":10,"first_seen":"2020-08-10","last_seen":"2026-08-10"}],"transactions":[{"id":9221461,"accession":"0001100682-26-000124","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001100682-26-000124","line_url":"/filing/0001100682-26-000124","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001543779","owner_name":"Knell Michael Gunnar","owner_display_name":"Knell Michael Gunnar","owner_url":"/insider/0001543779","role":"Officer (SVP, Finance and CAO)","role_mark":"O","role_mark_label":"Officer (SVP, Finance and CAO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Finance and CAO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6645.0,"shares_display":"6,645","price_per_share":260.3837035364936,"price_display":"260.38","price_state":"stated","total_value":1730249.71,"total_display":"1,730,249.71","total_whole":"1,730,250","shares_owned_after":13977.0,"shares_owned_after_display":"13,977","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-06","filed_date":"2026-08-10","scope":"insider","n_lines":9},{"id":9228047,"accession":"0001127602-24-016791","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-24-016791","line_url":"/filing/0001127602-24-016791#line-1","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001543779","owner_name":"Knell Michael Gunnar","owner_display_name":"Knell Michael Gunnar","owner_url":"/insider/0001543779","role":"Officer (CSVP&Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (CSVP&Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CSVP&Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":808.0,"shares_display":"808","price_per_share":267.52,"price_display":"267.52","price_state":"stated","total_value":216156.16,"total_display":"216,156.16","total_whole":"216,156","shares_owned_after":7825.0,"shares_owned_after_display":"7,825","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-08","filed_date":"2024-05-29","scope":"insider"},{"id":2722336,"accession":"0001127602-24-009396","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-24-009396","line_url":"/filing/0001127602-24-009396#line-1","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001543779","owner_name":"Knell Michael Gunnar","owner_display_name":"Knell Michael Gunnar","owner_url":"/insider/0001543779","role":"Officer (CSVP&Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (CSVP&Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CSVP&Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":808.0,"shares_display":"808","price_per_share":267.52,"price_display":"267.52","price_state":"stated","total_value":216156.16,"total_display":"216,156.16","total_whole":"216,156","shares_owned_after":7024.0,"shares_owned_after_display":"7,024","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-08","filed_date":"2024-03-11","scope":"insider"},{"id":2052850,"accession":"0001127602-24-008566","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-24-008566","line_url":"/filing/0001127602-24-008566","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001543779","owner_name":"Knell Michael Gunnar","owner_display_name":"Knell Michael Gunnar","owner_url":"/insider/0001543779","role":"Officer (CSVP&Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (CSVP&Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CSVP&Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2750.0,"shares_display":"2,750","price_per_share":261.0509090909091,"price_display":"261.05","price_state":"stated","total_value":717890.0,"total_display":"717,890.00","total_whole":"717,890","shares_owned_after":8832.0,"shares_owned_after_display":"8,832","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-04","filed_date":"2024-03-05","scope":"insider","n_lines":2},{"id":7893899,"accession":"0001127602-23-022486","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-23-022486","line_url":"/filing/0001127602-23-022486#line-2","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001543779","owner_name":"Knell Michael Gunnar","owner_display_name":"Knell Michael Gunnar","owner_url":"/insider/0001543779","role":"Officer (CSVP&Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (CSVP&Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CSVP&Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1471.0,"shares_display":"1,471","price_per_share":216.54,"price_display":"216.54","price_state":"stated","total_value":318530.34,"total_display":"318,530.34","total_whole":"318,530","shares_owned_after":9940.0,"shares_owned_after_display":"9,940","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-10","filed_date":"2023-08-14","scope":"insider"},{"id":6217907,"accession":"0001127602-22-025979","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-22-025979","line_url":"/filing/0001127602-22-025979#line-2","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001543779","owner_name":"Knell Michael Gunnar","owner_display_name":"Knell Michael Gunnar","owner_url":"/insider/0001543779","role":"Officer (CSVP&Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (CSVP&Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CSVP&Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":855.0,"shares_display":"855","price_per_share":248.59,"price_display":"248.59","price_state":"stated","total_value":212544.45,"total_display":"212,544.45","total_whole":"212,544","shares_owned_after":6438.0,"shares_owned_after_display":"6,438","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-16","filed_date":"2022-11-17","scope":"insider"},{"id":5541102,"accession":"0001127602-21-019395","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001127602-21-019395","line_url":"/filing/0001127602-21-019395#line-4","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001543779","owner_name":"Knell Michael Gunnar","owner_display_name":"Knell Michael Gunnar","owner_url":"/insider/0001543779","role":"Officer (CSVP&Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (CSVP&Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CSVP&Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1527.0,"shares_display":"1,527","price_per_share":335.2364,"price_display":"335.24","price_state":"stated","total_value":511905.9828,"total_display":"511,905.98","total_whole":"511,906","shares_owned_after":4230.0,"shares_owned_after_display":"4,230","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-04","filed_date":"2021-06-07","scope":"insider"},{"id":4133428,"accession":"0001127602-21-019153","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001127602-21-019153","line_url":"/filing/0001127602-21-019153#line-3","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001543779","owner_name":"Knell Michael Gunnar","owner_display_name":"Knell Michael Gunnar","owner_url":"/insider/0001543779","role":"Officer (CSVP&Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (CSVP&Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CSVP&Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":800.0,"shares_display":"800","price_per_share":329.7611,"price_display":"329.76","price_state":"stated","total_value":263808.88,"total_display":"263,808.88","total_whole":"263,809","shares_owned_after":4230.0,"shares_owned_after_display":"4,230","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-03","filed_date":"2021-06-04","scope":"insider"},{"id":5371328,"accession":"0001127602-21-007207","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-21-007207","line_url":"/filing/0001127602-21-007207#line-1","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001543779","owner_name":"Knell Michael Gunnar","owner_display_name":"Knell Michael Gunnar","owner_url":"/insider/0001543779","role":"Officer (CSVP&Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (CSVP&Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CSVP&Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":410.0,"shares_display":"410","price_per_share":290.9866,"price_display":"290.99","price_state":"stated","total_value":119304.506,"total_display":"119,304.51","total_whole":"119,305","shares_owned_after":4198.0,"shares_owned_after_display":"4,198","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-19","filed_date":"2021-02-23","scope":"insider"},{"id":2428498,"accession":"0001127602-20-023220","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001127602-20-023220","line_url":"/filing/0001127602-20-023220","is_derivative":false,"issuer_cik":"0001100682","issuer_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","issuer_ticker":"CRL","issuer_name_source":null,"issuer_url":"/issuer/0001100682","owner_cik":"0001543779","owner_name":"Knell Michael Gunnar","owner_display_name":"Knell Michael Gunnar","owner_url":"/insider/0001543779","role":"Officer (CSVP&Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (CSVP&Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CSVP&Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3456.0,"shares_display":"3,456","price_per_share":216.59591901041668,"price_display":"216.60","price_state":"stated","total_value":748555.4961,"total_display":"748,555.50","total_whole":"748,555","shares_owned_after":3062.0,"shares_owned_after_display":"3,062","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-07","filed_date":"2020-08-10","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":20,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":20,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":20},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001100682","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","url":"/issuer/0001100682","role":"Officer (SVP, Finance and CAO)","n_filings":10,"first_seen":"2020-08-10","last_seen":"2026-08-10"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001543779","retrieved_at":"2026-08-26T10:28:20+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}